Could a simple handheld device let kidney patients skip frequent clinic blood tests?
NCT ID NCT07392710
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tested a small, handheld device called the Nova Max Pro StatSensor that measures creatinine levels in the blood, a key marker of kidney function. The goal was to see if kidney transplant patients could use it reliably at home, compared to standard lab tests. One hundred patients participated, with a smaller group testing the device at home and sharing their experience through questionnaires and interviews.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Nova Max Pro StatSensor device (handheld creatinine monitor)
- What this could lead to
- If successful, this device could allow kidney transplant patients to reliably monitor their kidney function at home, reducing the need for frequent clinic visits and enabling earlier detection of problems.
- What could go wrong
- This is a small, completed study focused on accuracy and patient experience, not on treatment outcomes. The device may not be as accurate as lab tests, and home use may not suit everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY DISEASE, CHRONIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Royal Free Hospital
London, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could the choice of anesthesia quiet the Body's surgical stress response?
- A simple blood test could spot kidney transplant rejection early
- Can your gut bacteria change how transplant drugs work?
- Blood test may take the guesswork out of transplant drug dosing
- Dialysis's hidden water waste: can a simple flow change cut consumption without harming patients?
- Immunotherapy may treat skin cancer in kidney transplant patients without rejection